Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year.
“This…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions:
"As of today BIO will be pausing our political giving so we can…
Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing…
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant…
Innovative breakthroughs can secure our nation’s food supply by reducing greenhouse gas emissions throughout agricultural supply chains; strengthening producers’ resiliency to climate change while increasing production; and tackling hunger and…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners.
Science experts have been sounding the alarm since March when lockdowns started, that this pandemic is a drill for the impending climate change pandemic.
“Many organizations have warned that COVID-19 is only a…
In the wake of the violent riot at the U.S. Capitol last week, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath condemned the attack and announced that all political donations by…
If there’s a silver lining to the past year, it’s that we’ve learned a lot about how to accelerate innovation and get breakthroughs to patients, even in the most trying times.
On January 11, 2021, BIO President and CEO…